Rab6A as a pan-astrocytic marker in mouse and human brain, and comparison with other glial markers (GFAP, GS, Aldh1L1, SOX9)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Cells 19.2021, Article 72, doi:10.3390/cells10010072, ISSN 2073-4409
- Ereignis
-
Veröffentlichung
- (wo)
-
Frankfurt am Main
- (wer)
-
Universitätsbibliothek Johann Christian Senckenberg
- (wann)
-
2021
- Urheber
- URN
-
urn:nbn:de:hebis:30:3-574879
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Melzer, Linda
- Freiman, Thomas Michael
- Derouiche, Amin
- Universitätsbibliothek Johann Christian Senckenberg
Entstanden
- 2021
Ähnliche Objekte (12)
Glial activation markers in CSF and serum from patients with primary progressive multiple sclerosis: potential of serum GFAP as disease severity marker?
Expression of radial glial markers (GFAP, BLBP and GS) during telencephalic development in the catshark (Scyliorhinus canicula)
Oligodendrocyte Lineage Marker Expression in eGFP-GFAP Transgenic Mice
Vascular risk factors and astrocytic marker for the glymphatic system activity
Glutamine synthetase as an astrocytic marker: its cell type and vesicle localization
Common olfactory ensheathing glial markers in the developing human olfactory system
Serum GFAP in multiple sclerosis: correlation with disease type and MRI markers of disease severity
Blood levels of Glial Fibrillary Acidic Protein (GFAP) in patients with neurological diseases
Altered glial marker expression in autistic post-mortem prefrontal cortex and cerebellum
More than cell markers: understanding heterogeneous glial responses to implantable neural devices
Prediction of clinical progression in nervous system diseases: plasma glial fibrillary acidic protein (GFAP)
Seasonal Fluctuations of Glial Fibrillary Acidic Protein (GFAP) Immunoreactivity in the Rat Suprachiasmatic Nucleus
Glial activation markers in CSF and serum from patients with primary progressive multiple sclerosis: potential of serum GFAP as disease severity marker?
Expression of radial glial markers (GFAP, BLBP and GS) during telencephalic development in the catshark (Scyliorhinus canicula)
Oligodendrocyte Lineage Marker Expression in eGFP-GFAP Transgenic Mice
Vascular risk factors and astrocytic marker for the glymphatic system activity
Glutamine synthetase as an astrocytic marker: its cell type and vesicle localization
Common olfactory ensheathing glial markers in the developing human olfactory system
Serum GFAP in multiple sclerosis: correlation with disease type and MRI markers of disease severity
Blood levels of Glial Fibrillary Acidic Protein (GFAP) in patients with neurological diseases
Altered glial marker expression in autistic post-mortem prefrontal cortex and cerebellum
More than cell markers: understanding heterogeneous glial responses to implantable neural devices
Prediction of clinical progression in nervous system diseases: plasma glial fibrillary acidic protein (GFAP)
Seasonal Fluctuations of Glial Fibrillary Acidic Protein (GFAP) Immunoreactivity in the Rat Suprachiasmatic Nucleus
Glial activation markers in CSF and serum from patients with primary progressive multiple sclerosis: potential of serum GFAP as disease severity marker?
Expression of radial glial markers (GFAP, BLBP and GS) during telencephalic development in the catshark (Scyliorhinus canicula)
Oligodendrocyte Lineage Marker Expression in eGFP-GFAP Transgenic Mice
Vascular risk factors and astrocytic marker for the glymphatic system activity
Glutamine synthetase as an astrocytic marker: its cell type and vesicle localization
Common olfactory ensheathing glial markers in the developing human olfactory system
Serum GFAP in multiple sclerosis: correlation with disease type and MRI markers of disease severity
Blood levels of Glial Fibrillary Acidic Protein (GFAP) in patients with neurological diseases
Altered glial marker expression in autistic post-mortem prefrontal cortex and cerebellum
More than cell markers: understanding heterogeneous glial responses to implantable neural devices
Prediction of clinical progression in nervous system diseases: plasma glial fibrillary acidic protein (GFAP)